← Open Payments lookup

OLUMIDE OYEYIPO: Open Payments

NPI 1922031608 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$248 in 13 payments from 10 companies in 2025. Trend: 2023 $679 · 2024 $662 · 2025 $248

Food & beverage: $248
CompanyPaymentsAmount
ABBVIE INC.3$66
Novo Nordisk Inc2$38
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24
SCPHARMACEUTICALS INC.1$22
Lilly USA, LLC1$22
Esperion Therapeutics, Inc.1$17
Amgen Inc.1$16
Novartis Pharmaceuticals Corporation1$15
GlaxoSmithKline, LLC.1$14
Aimmune Therapeutics, Inc.1$14

Products named: VRAYLAR, XIFAXAN, FUROSCIX, MOUNJARO, Rybelsus, Wegovy, NEXLETOL, REPATHA.

Industry payments across FL — which companies pay providers there.